IDF Diabetes Atlas 2022 Reports
The IDF Diabetes Atlas aims to provide regular information on the state of diabetes in the world today. IDF Diabetes Atlas reports, produced annually, present new epidemiological and diabetes-related impact data.
In 2022, we took a deeper look into the impact of type 2 diabetes in indigenous peoples, type 1 diabetes across all age groups, COVID-19 among people with diabetes, and diabetes foot-related complications. This work presents a global view of the growing impact of diabetes and the urgent need for government and policymakers to take action.
IDF Diabetes Atlas report on diabetes among Indigenous Peoples
There over 476 million indigenous peoples, belonging to over 5,000 distinct groups, in over 90 countries around the world. The disruption and oppression suffered as a result of colonisation has contributed to disparate health outcomes that continue to impact these populations today. Subsequently, diabetes has become one of the most common health disparities disproportionately affecting indigenous populations around the globe.
IDF Diabetes Atlas report on type 1 diabetes estimates in children and adults
Until recently, the number of people living with type 1 diabetes across the globe was only estimated for children and adolescents less than 20 years of age. This has been due to insufficient data available for adult populations. The development of the Type 1 Diabetes Index (T1D Index) has now permitted more current and accurate estimates to be calculated for all ages across all countries. The T1D Index is a joint initiative between JDRF, Life for a Child, IDF, and the International Society for Pediatric and Adolescent Diabetes (ISPAD). In this report, global and country estimates of the number of people with type 1 diabetes for all age groups are presented.
IDF Diabetes Atlas report on diabetes foot-related complications
Having diabetes puts individuals at greater risk of foot problems, including diabetic peripheral neuropathy (DPN), which causes a lack of sensation in the foot due to elevated glucose levels; and peripheral arterial disease (PAD), symptoms of which can include foot ulcers and open sores that do not heal, leading to infections and even amputations. There is wide global variation in diabetes-related foot complications due to varying definitions, diagnostic methods, population characteristics, methods for handling data and provision of services.
IDF Diabetes Atlas report on the impact of diabetes on COVID-19 severity and death
Diabetes is a strong risk factor for adverse COVID-19 outcomes. To better understand the relationship between diabetes and COVID-19, 3,799 articles and 91 studies were assessed and analysed. Significant findings included that excess deaths and critical illnesses due to COVID-19 were greater for people with type 1 diabetes than for people with type 2 diabetes, and poor glycaemic control was a risk factor for adverse COVID-19 endpoints.
People with diabetes and HbA1C levels over or equal to 7% were 35 to 40% more likely to incur severe illness, including hospitalisation, if they contracted COVID-19.